Pharma Stocks

Why Amphastar Pharmaceuticals (AMPH) Shares Are Sliding Today

What Happened? Shares of pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) fell 5.7% in the afternoon session after Jefferies downgraded the stock…

Read More »

Aurobindo Pharma Sees Sharp Open Interest Surge Signallin…

Open Interest and Volume Dynamics The latest data reveals that Aurobindo Pharma’s open interest in derivatives rose sharply by 27.56%,…

Read More »

Is its U.S. generics push strong enough to unlock new upside?

Lupin Ltd leverages a robust generics portfolio with growing U.S. approvals, positioning it as a key player in affordable drugs…

Read More »

Is pharma packaging demand strong enough to drive steady gains

Gerresheimer AG specializes in critical packaging for pharmaceuticals and drug delivery, positioning it as a resilient play amid rising global…

Read More »

Why does its pharma pivot matter more now for global investors?

As Bayer shifts focus to pharmaceuticals amid crop science pressures, you need to weigh if this strategy delivers the stability…

Read More »

Aurobindo Pharma Sees Sharp Open Interest Surge Amid Mixe…

Open Interest and Volume Dynamics The latest data reveals that Aurobindo Pharma’s open interest in derivatives jumped by 15,841 contracts,…

Read More »

Is its pharma packaging dominance strong enough for U.S. inves

Gerresheimer AG specializes in critical packaging for drugs and medical devices, positioning it at the heart of global healthcare demand.…

Read More »

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Zealand Pharma Company announcement – No. 8 / 2026 Transactions in Zealand Pharma shares and/or related securities by persons discharging…

Read More »

2 Under-the-Radar Biotech Stocks Worth Buying for the Long Term

Vertex Pharmaceuticals (VRTX +1.27%) and Mirum Pharmaceuticals (MIRM +2.34%) are two biotech stocks that share the same blueprint. They are…

Read More »

Assessing Teva Pharmaceutical Industries (NYSE:TEVA) Valuation After The Home Ground Schizophrenia Platform Launch

Teva Pharmaceutical Industries (NYSE:TEVA) has launched Home Ground Schizophrenia Community, an online platform aimed at supporting people living with schizophrenia…

Read More »